Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Icon Wealth Advisors LLC

Icon Wealth Advisors LLC increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 1,910.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 300,889 shares of the company’s stock after purchasing an additional 285,920 shares during the period. Icon Wealth Advisors LLC owned approximately 0.25% of Privia Health Group worth $5,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PRVA. Vanguard Group Inc. increased its holdings in shares of Privia Health Group by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock valued at $223,327,000 after purchasing an additional 121,701 shares in the last quarter. Millennium Management LLC grew its position in Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after buying an additional 1,101,730 shares during the period. Dimensional Fund Advisors LP increased its holdings in Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after buying an additional 173,934 shares in the last quarter. First Light Asset Management LLC acquired a new position in shares of Privia Health Group in the first quarter worth about $21,620,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Privia Health Group by 6.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock worth $19,380,000 after acquiring an additional 65,152 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PRVA. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Barclays lifted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Truist Financial lifted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. KeyCorp assumed coverage on Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective on the stock. Finally, Robert W. Baird increased their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $25.07.

Insider Buying and Selling

In other news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This represents a 35.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.20% of the stock is owned by company insiders.

Privia Health Group Stock Up 1.9 %

Shares of PRVA opened at $21.18 on Friday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.30. The stock has a fifty day simple moving average of $18.91 and a two-hundred day simple moving average of $18.56. The company has a market capitalization of $2.54 billion, a PE ratio of 211.77, a price-to-earnings-growth ratio of 5.26 and a beta of 0.76.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.